FDA Commissioner Marty Makary has faced criticism over his leadership of the agency that oversees vaccine and drug approvals.
May 8, 2026 at 7:19 p.m. EDTyesterday at 7:19 p.m. EDT
Marty Makary at an event on health care affordability at the White House in April. (Mark Schiefelbein/AP)
White House officials have signed off on a plan to replace Food and Drug Administration Commissioner Marty Makary after months of turmoil at the agency and criticism of some of his decisions, according to two individuals who spoke on the condition of anonymity to describe internal operations.